Tyche Industries Ltd. (BSE: 532384) is a Hyderabad, Telangana-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹107 Cr, it ranks #3,188 by market cap among the 6,197 Indian listed companies on FinBizNet, and #68 of 86 in Medicinal Chemicals and Botanical Products. At ₹105.00 (as of 16 Nov 2026), the share price is 29.1% below its 52-week high of ₹148.00 and 7.1% above its 52-week low of ₹98.00. The share price is down 21.5% over one year and down 0.2% over three months.
| Current Price | ₹105.00 |
|---|---|
| Market Cap | ₹107 Cr |
| BSE Code | 532384 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products |
| P/E Ratio | 16 |
| Return on Equity | 5.01% |
| Return on Assets | 0.33% |
| 52-Week Range | ₹98.00 – ₹148.00 |
| 1-Year Price Change | -21.5% |
| 3-Month Price Change | -0.2% |
| Beta (1Y) | 0.41 |
| Dividend Yield | 3.27% |
| Headquarters | Hyderabad, Telangana |
| Website | www.tycheindustries.net |
Delivery averaged 83.9% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).
Tyche Industries Limited manufactures and sells active pharmaceutical ingredients and intermediates in India and internationally. The company also provides chiral intermediates and nutraceuticals; and contract drug substance and analytical development, as well as contract development, manufacturing, and analytical development services. It primarily exports its products to the United States and Europe. Tyche Industries Limited was incorporated in 1998 and is based in Hyderabad, India.
1. Pharmaceuticals-This segment manufactures and sells active pharmaceutical ingredients and intermediates.
1. APIs-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4,56,425 Cr | 39.5 | 14.72% | ₹16,199 Cr | +11.2% |
| Laurus Labs Ltd | ₹1,31,242 Cr | 145.6 | 17.74% | ₹2,206 Cr | +146.8% |
| Zydus Lifesciences Ltd | ₹1,19,651 Cr | 24.1 | 18.32% | ₹7,910 Cr | +26.0% |
| Dr.Reddys Lab | ₹1,15,464 Cr | 26.9 | 11.52% | ₹8,698 Cr | +14.5% |
| Cipla Limited | ₹1,14,712 Cr | 29.3 | 11.74% | ₹7,404 Cr | -7.6% |
| Mankind Pharma | ₹1,09,870 Cr | 57 | 12.45% | ₹4,338 Cr | +16.7% |
| Aurobindo Pharma Ltd. | ₹1,05,150 Cr | 30 | 9.93% | ₹10,263 Cr | +59.8% |
| Lupin Ltd | ₹92,087 Cr | 17.3 | 26.91% | ₹7,827 Cr | +0.4% |
| Tyche Industries Ltd. | ₹107 Cr | 16 | 5.01% | — | -21.5% |
Listed by market capitalisation. Ratios are shown for context only.
Tyche Industries Ltd. is trading at ₹105.00, with a market capitalisation of ₹107 Cr.
Tyche Industries Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).
Tyche Industries Ltd. has a P/E of 16 and a return on equity of 5.01%.
Tyche Industries Ltd. is listed on the BSE under the scrip code 532384.
Tyche Industries Ltd.'s share price is down 21.5% over one year and down 0.2% over three months. Its 52-week range is ₹98.00 to ₹148.00.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.